Nivestim (filgrastim): a new, convenient, daily G-CSF is effective for the prevention of febrile neutropenia

Clinical research has shown that Nivestim can reduce the duration of chemotherapy-induced neutropenia (CIN) and prevent febrile neutropenia (FN) in patients with cancer.